Maple syrup urine disease
Cranial ultrasonography in maple syrup urine disease
5
E2 transacylase deficient (type II) maple syrup urine disease Aberrant splicing of E2 mRNA caused by internal intronic deletions and association with thiamine responsive phenotype
10
Case report: maple syrup urine disease with a novel DBT gene mutation
5
Nasogastric Drip Feeding as the Only Treatment of Neonatal Maple Syrup Urine Disease
6
Outcome of Early and Long-Term Management of Classical Maple Syrup Urine Disease
9
Maple syrup urine disease presenting as severe neonatal metabolic encephalopathy: a case report
5
Evidence for both a regulatory mutation and a structural mutation in a family with maple syrup urine disease
6
Molecular and biochemical basis of intermediate maple syrup urine disease Occurrence of homozygous G245R and F364C mutations at the E1 alpha locus of Hispanic Mexican patients
11
THE DIAGNOSIS OF MAPLE SYRUP URINE DISEASE (Branched-chain Ketoaciduria)
7
ENU mutagenesis identifies mice with mitochondrial branched chain aminotransferase deficiency resembling human maple syrup urine disease
8
Maple syrup urine disease Complete defect of the E1 beta subunit of the branched chain alpha ketoacid dehydrogenase complex due to a deletion of an 11 bp repeat sequence which encodes a mitochondrial targeting leader peptide in a family with the disease
6
Maple syrup urine disease caused by a partial deletion in the inner E2 core domain of the branched chain alpha keto acid dehydrogenase complex due to aberrant splicing A single base deletion at a 5' splice donor site of an intron of the E2 gene disrupts the consensus sequence in this region
6
Altered kinetic properties of the branched chain alpha keto acid dehydrogenase complex due to mutation of the beta subunit of the branched chain alpha keto acid decarboxylase (E1) component in lymphoblastoid cells derived from patients with maple syrup urine disease
9
Brain–blood amino acid correlates following protein restriction in murine maple syrup urine disease
8
Case report: Aqueous and Vitreous amino-acid concentrations in a patient with maple syrup urine disease operated on rhegmatogenous retinal detachment
6
Newborn Screening for Maple Syrup Urine Disease (Branched-Chain Ketoaciduria)
7
Maple syrup urine disease Complete primary structure of the E1 beta subunit of human branched chain alpha ketoacid dehydrogenase complex deduced from the nucleotide sequence and a gene analysis of patients with this disease
7
Glucose and Alanine Metabolism in Children with Maple Syrup Urine Disease
9
Maple syrup urine disease: mechanisms and management
10
Intermittent Maple Syrup Urine Disease: Two Case Reports
5